Moreover, the findings from patient samples validated that the protein levels of STC1, HMOX1 and TGFB1 were significantly higher in GBM tissues than in adjacent brain tissues (Figure 4D), implying that these genes could be potential biopsy biomarkers for GBM diagnosis. Here, STC1 is linked to glioblastoma.